z-logo
open-access-imgOpen Access
Randomized trial of standard adjuvant chemotherapy regimens versus capecitabine in older women with early breast cancer: 10-year update of the CALGB 49907 trial
Author(s) -
H.B. Muss,
M.-Y.C. Polley,
D.A. Berry,
H. Liu,
C.T. Cirrincione,
M. Theodoulou,
A.M. Mauer,
A.B. Kornblith,
A.H. Partridge,
L.G. Dressler,
H.J. Cohen,
P.A. Kartcheske,
E.A. Perez,
A.C. Wolff,
J.R. Gralow,
H.J. Burstein,
A.A. Mahmood,
L.M. Sutton,
G. Magrinat,
B.A. Parker,
R.D. Hart,
D. Grenier,
A. Hurria,
A. Jatoi,
L. Norton,
C.A. Hudis,
E.P. Winer,
L. Carey
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/dyvk-4p88
Subject(s) - capecitabine , medicine , oncology , breast cancer , randomized controlled trial , adjuvant chemotherapy , chemotherapy , adjuvant , cancer , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom